Keywords: merck, co, vorinostat, shows, early, efficacy, mm

Merck & Co's vorinostat shows early efficacy in MM

Article | 08 June 2009

Print This

Results from a Phase I study presented at the 14th annual meeting of the European Hematology Association in Berlin, Germany, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in